Parker, Richard https://orcid.org/0000-0003-4888-8670
Arab, Juan P. https://orcid.org/0000-0002-8561-396X
Lazarus, Jeffrey V. https://orcid.org/0000-0001-9618-2299
Bataller, Ramon https://orcid.org/0000-0002-1119-7799
Singal, Ashwani K. https://orcid.org/0000-0003-1207-3998
Article History
Accepted: 19 May 2025
First Online: 4 June 2025
Competing interests
: R.P. has received fees for speaking from Norgine and Orphalan, support to attend scientific meetings from Orphalan, and consulting fees from Durect Corporation and Novo Nordisk. The other authors declare no competing interests.